FDA Approval Summary: Sotorasib for KRAS G12C -Mutated Metastatic NSCLC - Nakajima, Erica C.; Drezner, Nicole; Li, Xiaoxue; Mishra-Kalyani, Pallavi S.; Liu, Yajun; Zhao, Hong; Bi, Youwei; Liu, Jiang; Rahman, Atiqur; Wearne, Emily; Ojofeitimi, Idara; Hotaki, Lauren Tesh; et al. (Clinical cancer research, 2022)
Keywords: Carcinoma, Non-Small-Cell Lung - drug therapy; Carcinoma, Non-Small-Cell Lung - genetics; Clinical Trials, Phase I as Topic; Humans; Lung Neoplasms - chemically induced; Lung Neoplasms - drug therapy; Lung Neoplasms - genetics; Mutation; Piperazines - therapeutic use; Proto-Oncogene Proteins p21(ras) - genetics; Pyridines; Pyrimidines